Liming Zhang

Mr. Liming Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2021 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
HCHaiqing Chu
Haiqing Chu
JWJiexin Wang
Jiexin Wang
QWQian Wang
Qian Wang
JCJie Chen
Jie Chen
JLJiaoning Li
Jiaoning Li
LZLiming Zhang
Liming Zhang

15 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
WYWenqian Yang
Wenqian Yang
FSFei Shao
Fei Shao
JWJiexin Wang
Jiexin Wang
TSTong Shen
Tong Shen
YZYu Zhao
Yu Zhao
HLHangying Li
Hangying Li
Background: Immunological liver injury (ILI) is a common liver disease and lacks potent drugs for treatment. Artemisia argyi Lévl. et Vant. (A. argyi), a medicinal and edible homologous plant usually used in diet therapy to cure various liver diseases, provides a great option for the prevention of ILI. Purpose: To investigate the effect that ethyl acetate extract of A. argyi (AaEA) on Concanavalin A (ConA)-induced ILI and the mechanism of regulating Bax/Bcl-2 and TLR4/MyD88/NF-κB signaling pathways. Methods: The chemical components of AaEA were studied by LC-MS. In animal experiments, the positive control group was administrated diammonium glycyrrhizinate (DIG, 100 mg/kg), while different doses of AaEA groups (AaEA-H, AaEA-M, AaEA-L) were pretreated with AaEA 2.00, 1.00, and 0.50 g/kg, respectively, by intragastric for seven days, once every day. Then, ConA (12.00 mg/kg) was used through tail intravenous injection to establish the ILI model. The blood samples and livers were collected to test the degree of liver dysfunction, inflammation, oxidative stress, histopathological changes, and cell apoptosis. Real-time PCR and Western blotting analysis were used to explain the mechanism of regulating Bax/Bcl-2 and TLR4/MyD88/NF-κB signaling pathways. Results: The way in which AaEA prevents liver damage in immunological liver injury (ILI) mice caused by ConA was investigated for the first time. Pretreatment with AaEA reduced the expression of ALT, AST, and inflammatory factors (TNF-α and IFN-γ). Meanwhile, AaEA also reduced MDA levels but upregulated the contents of IL-4, SOD, and GSH-px, alleviating oxidative stress induced by ILI. Western blotting and real-time PCR analysis demonstrated that AaEA could regulate the expression level and relative mRNA expression of key proteins on Bax/Bcl-2 and TLR4/MyD88/NF-κB signaling pathways. Finally, 504 components from AaEA were identified by LC-MS analysis, mainly including flavones, phenolic acids, and terpenoids with anti-inflammatory and liver protective activities, which highlights the potential of AaEA for diet treatment of ILI. Conclusion: AaEA can work against ConA-induced ILI in mice by regulating Bax/Bcl-2 and TLR4/MyD88/NF-κB signaling pathways, which has the potential to be a great strategy for the prevention of ILI.

15 March 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
QLQian Liu
Qian Liu
CYCheng Yang
Cheng Yang
JQJiamin Qi
Jiamin Qi
QSQiying Shen
Qiying Shen
MYMingxing Ye
Mingxing Ye
LZLiming Zhang
Liming Zhang

24 July 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JWJiexin Wang
Jiexin Wang
HCHaiqing Chu
Haiqing Chu
HLHangying Li
Hangying Li
WYWenqian Yang
Wenqian Yang
YZYu Zhao
Yu Zhao
LZLiming Zhang
Liming Zhang
Erjing prescription (EJP) was an ancient formula that was recorded in the General Medical Collection of Royal Benevolence of the Song Dynasty. It has been frequently used to treat type 2 diabetes mellitus (T2DM) in the long history of China. The formula consists of Lycium barbarum L. and Polygonatum sibiricum F. Delaroche with a ratio of 1:1. This study aimed to identify the potential effects and mechanisms of EJP treatment T2DM. The target proteins and possible pathways of EJP in T2DM treatment were investigated by the approach of network pharmacology and real-time PCR (RT-PCR). 99 diabetes-related proteins were regulated by 56 bioactive constituents in EJP in 26 signal pathways by Cytoscape determination. According to GO analysis, 606 genes entries have been enriched. The PPI network suggested that AKT1, EGF, EGFR, MAPK1, and GSK3β proteins were core genes. Among the 26 signal pathways, the PI3K-AKT signal pathway was tested by the RT-PCR. The expression level of PI3K p85, AKT1, GSK3β, and Myc mRNA of this pathway was regulated by EJP. The study based on network pharmacology and RT-PCR analysis revealed that the blood sugar level was regulated by EJP via regulating the PI3K-AKT signal pathway. Plenty of new treatment methods for T2DM using EJP were provided by network pharmacology analysis.

10 September 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
QSQiying Shen
Qiying Shen
MYMingxing Ye
Mingxing Ye
JWJiexin Wang
Jiexin Wang
QLQian Liu
Qian Liu
RWRui Wu
Rui Wu
LZLiming Zhang
Liming Zhang

28 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
CZCaiping Zhao
Caiping Zhao
MYMingxing Ye
Mingxing Ye
HCHaiQing Chu
HaiQing Chu
HLHangYing Li
HangYing Li
LZLiming Zhang
Liming Zhang
Type 2 diabetes mellitus (T2DM) is a common and highly prevalent metabolic disorder. The classical herbal formula Erjing Prescription (EJP) possesses pharmacological effects such as hypoglycemic, lipid-lowering, and anti-inflammatory actions. This study aimed to investigate the therapeutic effects of EJP on T2DM, as well as its potential mechanisms and bioactive components. A T2DM rat model and an insulin-resistant (IR) HepG2 cell model were established to evaluate the therapeutic effects of EJP. Hypoglycemic capacity was assessed by measuring fasting blood glucose and glucose uptake levels; the ability to improve histopathological damage and inhibit apoptosis was evaluated using hematoxylin-eosin (HE) staining and Annexin V-FITC/PI staining; antioxidant and anti-inflammatory levels were assessed by measuring SOD, MDA, TNF-α, IL-6, and IL-1β; and the bioactive components of EJP were analyzed using HPLC in conjunction with animal experiments. Finally, the mechanism of action of EJP was analyzed using Western blotting. The results showed that EJP can significantly slow the progression of T2DM by lowering blood glucose levels, suppressing inflammatory responses, and enhancing antioxidant and anti-apoptotic capabilities; its key molecular mechanism is attributed to the IRS1/PI3K/AKT signaling pathway. These findings indicate that EJP exerts its anti-T2DM effects by alleviating insulin resistance (IR) through activation of the IRS1/PI3K/AKT pathway. Therefore, EJP may serve as a potential novel therapeutic agent for T2DM.